Skip to content
Interested in access to new research? contact us
mymee for payers mymee for payers

Despite major advances in autoimmune treatment, an average 40% of rheumatic patients are non-responders to autoimmune biologics and targeted therapies in clinical trials. Over 70% do not sustain remission in the real world. These patients remain at risk of exposure to unique sensitivities in their exposome that drive worsening symptoms despite prescribed medication.

*Sources: Prime Therapeutics, Inc, CVS Payor Solutions, Published meta analysis of RA, PsA, AS IBM claims data, real world evidence studies & RCTs

Help your members reduce unpredictable rheumatic flares to significantly improve quality of life

What is Mymee?

Mymee is the first digital care solution proven to help patients experiencing debilitating flares despite autoimmune Rx. Members work with Mymee’s specialized health coaches in a guided personalized trial process. Key components include:

  • Patient mobile app customized weekly around unique data capture requirements for testing (e.g. symptoms, exposome variables) & on-demand messaging.
  • Data and knowledge management platform to capture, store, manage and analyze data.
  • Coach dashboard & tools to manage weekly personalized trial customization and analysis.

How does Mymee help plan members?

Mymee empowers patients with moderate to frequent rheumatic symptoms to significantly improve their quality of life within 17 weeks on average. In peer reviewed studies, >70% patients reversed moderate & severe flares to mild & normal (PROMISⓇ HRQoL). 

Members receive: 

  • Exposome risk analysis (food, environment, Rx) for correlating symptoms to triggers. 
  • Weekly analysis sessions with certified health coach to guide the personalized trial.
  • Precision care and nutrition, until they minimize flares while expanding daily activities.

How does Mymee help payers? 

Mymee helps payers increase value and lower risks for plan members while reducing healthcare costs. Members report >90% improvement in working with their rheumatologist to optimize autoimmune treatment. Through Mymee, payers saw: 

  • 45% patients stopped 1 drug or more, and 56% average reduction in steroid use.
  • 24% average reduction in biologics, with average gross annual Rx savings of $11,328/per patient on biologics.
  • Member satisfaction: Mymee 86 NPS* & 5-star reviews.

 

*NPS (Net Promoter Score) is a widely used metric asking respondents to rate the likelihood they would recommend a product or service to a friend or colleague. For comparison purposes, the average healthcare company has an NPS score of 58.

Mymee’s true patient-centered design drives engagement &  82% program completion to improve patient outcomes & value impact for payers

currency

Average gross annual Rx savings of $11,328 per patient on biologics defined by payer audited script reduction

smile

Statistically significant and clinically meaningful change among symptomatic patients across 10 HRQoL domains as measured by PROMIS-29. The more severe the symptom, the greater the average improvement

Layer 2

> 40% mean reduction in 59 patient-reported symptoms surveyed in personalized trials

meds_icon

Reduction in average # of prescription drugs among patients who were symptomatic at baseline

Learn more about supporting autoimmune patients through personalized trial & care

Read on for additional articles and insights related to Mymee’s research and use of coach-led personalized trials to guide statistically significant improvements in quality of life.  

shutterstock_1723725661
Mymee Patients Reverse Autoimmune Disease Flares (2)

PR Newswire: Mymee's Personalized Trial & Care Solution Helps Autoimmune Disease Patients Reverse Flares, New Research Shows

Read More
covid-long-haul-symptoms

Rheumatology Network: Self-Advocacy Platform Allows Patients with Autoimmune Diseases to Discover Triggers, Improve Disease Management

Read More
RA Patient Experiences Improvement With Mymee

PR Newswire: New Real-world Study Demonstrates Connection Between
Long COVID and Rheumatic Autoimmune Disease Symptoms and Environmental Triggers

Read More
Woman receives virtual lupus support through Mymee

ACR Meeting Abstract: How Becoming Engaged in My Care with Specialized Tools and Support Helped Me Find My Personal Lupus Triggers and Regain Control of My Health (Patient Perspective)

Read More
Screenshot 2023-03-21 at 6.13.05 PM

Journal of Medical Internet Research: Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus

Read More